Afatinib Dimaleate from Japan

Afatinib dimaleate is an irreversible EGFR inhibitor for non-small cell lung cancer. As a quinazoline-based aromatic nitrogen heterocycle drug, it falls under HTS 2933.99.75.00.

Duty Rate — Japan → United States

12.5%

Rate breakdown

9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%

Calculate with your customs value Verify classification with AI

Import Tips

• ,FDA prior notice required 72 hours before arrival for drug substances

• Use ISF importer security filing for ocean shipments of pharma APIs